Cargando…
Immune Therapy and β-Cell Death in Type 1 Diabetes
Type 1 diabetes (T1D) results from immune-mediated destruction of insulin-producing β-cells. The killing of β-cells is not currently measurable; β-cell functional studies routinely used are affected by environmental factors such as glucose and cannot distinguish death from dysfunction. Moreover, it...
Autores principales: | Lebastchi, Jasmin, Deng, Songyan, Lebastchi, Amir H., Beshar, Isabel, Gitelman, Stephen, Willi, Steven, Gottlieb, Peter, Akirav, Eitan M., Bluestone, Jeffrey A., Herold, Kevan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636605/ https://www.ncbi.nlm.nih.gov/pubmed/23423576 http://dx.doi.org/10.2337/db12-1207 |
Ejemplares similares
-
β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008) -
A Humanized Mouse Model of Autoimmune Insulitis
por: Viehmann Milam, Ashley A., et al.
Publicado: (2014) -
MON-679 What’s in a Bottle? the Importance of Careful Medication Review to Prevent Life Threatening Hypoglycemia
por: Banerjee, Ela, et al.
Publicado: (2020) -
Abstract #1042611: Impact of Diabetes and Glycemic Control on Poor Outcomes in Hospitalized Patients with Obesity and COVID-19 Infectionq2
por: Lebastchi, Jasmin, et al.
Publicado: (2021) -
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)